- Home
- PCVX vs NYT Comparison
PCVX vs NYT Comparison
Compare PCVX & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- NYT
- Stock Information
- Founded
- PCVX 2013
- NYT 1851
- Country
- PCVX United States
- NYT United States
- Employees
- PCVX N/A
- NYT N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- NYT Newspapers/Magazines
- Sector
- PCVX Health Care
- NYT Consumer Discretionary
- Exchange
- PCVX Nasdaq
- NYT Nasdaq
- Market Cap
- PCVX 13.2B
- NYT 8.3B
- IPO Year
- PCVX 2020
- NYT N/A
- Fundamental
- Price
- PCVX $78.14
- NYT $51.62
- Analyst Decision
- PCVX Strong Buy
- NYT Strong Buy
- Analyst Count
- PCVX 9
- NYT 5
- Target Price
- PCVX $149.38
- NYT $55.60
- AVG Volume (30 Days)
- PCVX 1.1M
- NYT 1.3M
- Earning Date
- PCVX 02-25-2025
- NYT 02-05-2025
- Dividend Yield
- PCVX N/A
- NYT 1.01%
- EPS Growth
- PCVX N/A
- NYT 45.39
- EPS
- PCVX N/A
- NYT 1.69
- Revenue
- PCVX N/A
- NYT $2,509,105,000.00
- Revenue This Year
- PCVX N/A
- NYT $8.83
- Revenue Next Year
- PCVX N/A
- NYT $6.47
- P/E Ratio
- PCVX N/A
- NYT $30.44
- Revenue Growth
- PCVX N/A
- NYT 5.01
- 52 Week Low
- PCVX $58.10
- NYT $41.55
- 52 Week High
- PCVX $121.06
- NYT $58.16
- Technical
- Relative Strength Index (RSI)
- PCVX 32.14
- NYT 39.85
- Support Level
- PCVX $80.10
- NYT $50.32
- Resistance Level
- PCVX $81.70
- NYT $53.42
- Average True Range (ATR)
- PCVX 3.12
- NYT 0.87
- MACD
- PCVX -0.13
- NYT -0.16
- Stochastic Oscillator
- PCVX 5.68
- NYT 37.90
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.